The lessen in paclitaxel CL observed in the existence of zosuquidar led to a increase in the time which the plasma paclitaxel concentration remains over 0.one mol L−1, which is understood being a marker of both equally toxicity (neutropenia) and efficacy [1]. Even though the outcome of zosuquidar to the https://jimib443rep7.newbigblog.com/profile